InsidersTradesSigma
파미셀 Stock: price and insider trades · South Korea · DART (FSS)
Track the 파미셀 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 파미셀 has published 49 reports. Market capitalisation: €670.8bn. The latest transaction was filed on 10 July 2026 (Other). Among the most active insiders: 김현수. All data is accessible without an account.
49
Insider Decl.
0
Thresholds
·
21 ops.
Buy Volume
·
1 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,419 of 26,102 companies
57.1
score / 100
Value52
Quality62
FCF yld4.6%
Earn yld5.5%
EV/EBITDA19.7x
ROE-29%
Gross mgn44%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 July 2026
Declarations49 total
25 of 49 declarations
About 파미셀
파미셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.